v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common stock:
Additional paid-in capital:
Treasury stock:
Accumulated other comprehensive income (loss):
Retained earnings (accumulated deficit):
Balance, beginning of period (in shares) at Jan. 31, 2025   266,352        
Balance, beginning of period at Jan. 31, 2025   $ 0 $ 11,463 $ (1,308) $ 84 $ (1,205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   4,679        
Issuance of common stock under employee equity plans   $ 0 111      
Shares withheld related to net share settlement of equity awards   $ 0 (374)      
Shares withheld related to net share settlement of equity awards (in shares)   (1,621)        
Share-based compensation     855      
Common stock repurchased (in shares)   (2,506)        
Common stock repurchases under share repurchase programs   $ (592)   (592)    
Other comprehensive income (loss) $ (158)       (158)  
Net income 296         296
Balance, end of period (in shares) at Jul. 31, 2025   266,904        
Balance, end of period at Jul. 31, 2025 9,172 $ 0 12,055 (1,900) (74) (909)
Balance, beginning of period (in shares) at Apr. 30, 2025   266,596        
Balance, beginning of period at Apr. 30, 2025   $ 0 11,701 (1,601) (44) (1,137)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   2,142        
Issuance of common stock under employee equity plans   $ 0 111      
Shares withheld related to net share settlement of equity awards   $ 0 (151)      
Shares withheld related to net share settlement of equity awards (in shares)   (618)        
Share-based compensation     394      
Common stock repurchased (in shares)   (1,216)        
Common stock repurchases under share repurchase programs   $ (299)   (299)    
Other comprehensive income (loss) (30)       (30)  
Net income 228         228
Balance, end of period (in shares) at Jul. 31, 2025   266,904        
Balance, end of period at Jul. 31, 2025 9,172 $ 0 12,055 (1,900) (74) (909)
Balance, beginning of period (in shares) at Jan. 31, 2026   259,131        
Balance, beginning of period at Jan. 31, 2026 7,805 $ 0 12,673 (4,220) (136) (512)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   5,889        
Issuance of common stock under employee equity plans   $ 0 98      
Shares withheld related to net share settlement of equity awards   $ 0 (277)      
Shares withheld related to net share settlement of equity awards (in shares)   (2,036)        
Share-based compensation     871      
Common stock repurchased (in shares)   (21,809)        
Common stock repurchases under share repurchase programs   $ (2,907)   (2,931)    
Other comprehensive income (loss) 40       40  
Net income 854         854
Balance, end of period (in shares) at Jul. 31, 2026   241,175        
Balance, end of period at Jul. 31, 2026 6,460 $ 0 13,365 (7,151) (96) 342
Balance, beginning of period (in shares) at Apr. 30, 2026   248,730        
Balance, beginning of period at Apr. 30, 2026   $ 0 12,932 (5,834) (125) (290)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under employee equity plans (in shares)   3,154        
Issuance of common stock under employee equity plans   $ 0 98      
Shares withheld related to net share settlement of equity awards   $ 0 (127)      
Shares withheld related to net share settlement of equity awards (in shares)   (926)        
Share-based compensation     462      
Common stock repurchased (in shares)   (9,783)        
Common stock repurchases under share repurchase programs   $ (1,307)   (1,317)    
Other comprehensive income (loss) 29       29  
Net income 632         632
Balance, end of period (in shares) at Jul. 31, 2026   241,175        
Balance, end of period at Jul. 31, 2026 $ 6,460 $ 0 $ 13,365 $ (7,151) $ (96) $ 342